Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Long Non-coding RNA LINC02195 as a Regulator of MHC I Molecules and Favorable Prognostic Marker for Head and Neck Squamous Cell Carcinoma
Ist Teil von
Frontiers in oncology, 2020-05, Vol.10, p.615-615
Ort / Verlag
Switzerland: Frontiers Research Foundation
Erscheinungsjahr
2020
Link zum Volltext
Quelle
EZB Free E-Journals
Beschreibungen/Notizen
The loss of major histocompatibility complex class I (MHC I) molecules is an important mechanism by which cancer cells escape immunosurveillance in head and neck squamous cell carcinoma (HNSCC). Several long non-coding RNAs (lncRNAs) have been implicated in immune response and regulation including antigen processing and presentation. However, few studies on lncRNAs regulating MHC I expression in HNSCC have been conducted. In this study, MHC I related lncRNAs were identified from the The Cancer Genome Atlas (TCGA) HNSCC database. One of the lncRNAs,
(
), was found to be associated with genes encoding MHC I molecules and patient prognosis in the TCGA database. KEGG and GO analyses suggested that
was closely related to antigen processing and presentation. qRT-PCR revealed high expression of
in human HNSCC tissues and HNSCC cell lines compared with normal mucosal tissues.
hybridization of the HNSCC tissue microarray revealed a correlation between high
expression and a favorable prognosis in our patient cohort. Silencing of
decreased MHC I protein expression, as evidenced by western blotting. Multiplex immunochemistry was performed to reveal the positive correlation between high
expression and an increased number of CD8
and CD4
T cells in the tumor microenvironment. Based on our study,
is a promising prognostic marker and a target for future therapeutic interventions.